Predictive validity in drug discovery: what it is, why it matters and how to improve it by Scannell, JW, Bosley, J, Hickman, JA, Dawson, GR, Truebel, H, Ferreira, GS, Richards, D, Treherne, JM

Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate by Downey, D, Dutta, A, McKie, S, Dawson, GR, Dourish, CT, Craig, K, Smith, MA, McCarthy, DJ, Harmer, CJ, Goodwin, GM, Williams, S, Deakin, JFW

Exploring the incidence of inadequate response to antidepressants in the primary care of depression by Abrahams, AB, Beckenstrom, AC, Browning, M, Dias, R, Goodwin, GM, Gorwood, P, Kingslake, J, Morriss, R, Reif, A, Ruhé, HG, Simon, J, Dawson, GR

When a test is more than just a test: findings from patient interviews and survey in the trial of a technology to measure antidepressant medication response (the PReDicT Trial) by Brown, S, Ploeger, C, Guo, B, Petersen, JJ, Beckenstrom, AC, Browning, M, Dawson, GR, Deckert, J, Dias, R, Dourish, CT, Gorwood, P, Kingslake, J, Menke, A, Sola, VP, Reif, A, Ruhe, H, Simon, J, Stäblein, M, van Schaik, A, Veltman, DJ, Morriss, R, PReDicT Group

From structure to clinic: design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer’s disease by Brown, AJH, Bradley, SJ, Marshall, FH, Brown, GA, Bennett, KA, Brown, J, Cansfield, JE, Cross, DM, Dias, JM, Errey, JC, Hurrell, E, Liptrot, J, Molloy, C, Nathan, PJ, Okrasa, K, Osbourne, G, Patel, JC, Pickworth, M, Robertson, N, Shahabi, S, Bundgaard, C, Phillips, K, Broad, LM, Goonawardena, AV, Morairty, SR, Browning, M, Perini, F, Dawson, GR, Deakin, JFW, Smith, RT, Sexton, PM, Warneck, J, Vinson, M, Tasker, T, Tehan, BG, Teobald, B, Christopoulos, A, Langmead, CJ, Jazayeri, A, Cooke, RM, Rucktooa, P, Congreve, MS, Weir, M, Tobin, A, Et al.